Vaccinex Inc (VCNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Sales | 523 | 724 | 90 | 316 | 0 |
| Cost of Goods | 199 | 1,033 | 160 | 115 | N/A |
| Gross Profit | 324 | -309 | -70 | 201 | N/A |
| Operating Expenses | 32,538 | 27,005 | 21,194 | 20,575 | 0 |
| Operating Income | -32,015 | -27,281 | -21,104 | -20,259 | N/A |
| Interest Expense | 0 | 392 | 1,358 | 2,990 | 0 |
| Other Income | 152 | -1,845 | 3,703 | 9,306 | 0 |
| Pre-tax Income | -31,863 | -29,518 | -18,759 | -13,943 | 0 |
| Net Income Continuous | -31,863 | -29,518 | -18,759 | -13,943 | N/A |
| Minority Interests | N/A | N/A | -37 | N/A | N/A |
| Net Income | $-31,863 | $-29,518 | $-18,722 | $-13,943 | $N/A |
| EPS Basic Total Ops | -518.65 | -1,186.38 | -4,178.58 | -5,306.17 | N/A |
| EPS Basic Continuous Ops | -519.41 | -1,186.48 | -3,574.41 | -2,820.56 | N/A |
| EPS Diluted Total Ops | -518.65 | -1,186.38 | -4,178.58 | -5,306.17 | N/A |
| EPS Diluted Continuous Ops | -519.41 | -1,186.48 | -3,574.41 | -2,820.56 | N/A |
| EPS Diluted Before Non-Recurring Items | -518.65 | -1,089.79 | N/A | N/A | N/A |
| EBITDA(a) | $-31,810 | $-26,850 | $-19,681 | $-18,515 | $N/A |